There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...
Medpage Today on MSN2d
FDA Adds New Warning to GLP-1 DrugsLabels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...
Hosted on MSN1d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?In October, the FDA removed Mounjaro and Zepbound—the diabetes and obesity GLP-1 drugs made by Eli Lilly—from the shortage ...
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications primarily used to treat type 2 diabetes. GLP-1s work by regulating the production of insulin and lowering your blood sugar.
In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...
New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...
Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...
Health on MSN5d
Smoothie King Has a New 'GLP-1 Support Menu'—What People on Obesity Drugs Need to KnowSmoothie King, a franchise that specializes in selling smoothies, recently launched a "GLP-1 Support Menu," made specifically ...
Glucagon-like peptide medications that treat Type 2 diabetes and weight management continue to grow in popularity, though ...
Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback